These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 37667052)

  • 1. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).
    Proal AD; VanElzakker MB; Aleman S; Bach K; Boribong BP; Buggert M; Cherry S; Chertow DS; Davies HE; Dupont CL; Deeks SG; Eimer W; Ely EW; Fasano A; Freire M; Geng LN; Griffin DE; Henrich TJ; Iwasaki A; Izquierdo-Garcia D; Locci M; Mehandru S; Painter MM; Peluso MJ; Pretorius E; Price DA; Putrino D; Scheuermann RH; Tan GS; Tanzi RE; VanBrocklin HF; Yonker LM; Wherry EJ
    Nat Immunol; 2023 Oct; 24(10):1616-1627. PubMed ID: 37667052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).
    Sherif ZA; Gomez CR; Connors TJ; Henrich TJ; Reeves WB;
    Elife; 2023 Mar; 12():. PubMed ID: 36947108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19.
    Craddock V; Mahajan A; Spikes L; Krishnamachary B; Ram AK; Kumar A; Chen L; Chalise P; Dhillon NK
    J Med Virol; 2023 Feb; 95(2):e28568. PubMed ID: 36756925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC).
    Mohandas S; Jagannathan P; Henrich TJ; Sherif ZA; Bime C; Quinlan E; Portman MA; Gennaro M; Rehman J;
    Elife; 2023 May; 12():. PubMed ID: 37233729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals.
    Leung JM; Wu MJ; Kheradpour P; Chen C; Drake KA; Tong G; Ridaura VK; Zisser HC; Conrad WA; Hudson N; Allen J; Welberry C; Parsy-Kowalska C; Macdonald I; Tapson VF; Moy JN; deFilippi CR; Rosas IO; Basit M; Krishnan JA; Parthasarathy S; Prabhakar BS; Salvatore M; Kim CC
    Front Immunol; 2024; 15():1348041. PubMed ID: 38318183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females.
    Jansen EB; Ostadgavahi AT; Hewins B; Buchanan R; Thivierge BM; Sganzerla Martinez G; Goncin U; Francis ME; Swan CL; Scruten E; Bell J; Darbellay J; Facciuolo A; Falzarano D; Gerdts V; Fenton ME; Hedlin P; Kelvin DJ; Kelvin AA
    Sci Rep; 2024 Apr; 14(1):9854. PubMed ID: 38684819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID.
    Islam MS; Wang Z; Abdel-Mohsen M; Chen X; Montaner LJ
    J Leukoc Biol; 2023 Mar; 113(3):236-254. PubMed ID: 36807444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-acute sequelae of SARS-CoV-2 mimic: An important neurological condition.
    Ohira M; Osada T; Kimura H; Sano T; Takao M
    J Neurol Sci; 2024 Oct; 465():123199. PubMed ID: 39182422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral persistence, reactivation, and mechanisms of long COVID.
    Chen B; Julg B; Mohandas S; Bradfute SB;
    Elife; 2023 May; 12():. PubMed ID: 37140960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH RECOVER study.
    Hill EL; Mehta HB; Sharma S; Mane K; Singh SK; Xie C; Cathey E; Loomba J; Russell S; Spratt H; DeWitt PE; Ammar N; Madlock-Brown C; Brown D; McMurry JA; Chute CG; Haendel MA; Moffitt R; Pfaff ER; Bennett TD; ;
    BMC Public Health; 2023 Oct; 23(1):2103. PubMed ID: 37880596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19.
    Goetzl EJ; Yao PJ; Kapogiannis D
    Am J Med; 2023 Aug; 136(8):824-829. PubMed ID: 37072092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health record-based analysis from the RECOVER initiative.
    L Mandel H; Colleen G; Abedian S; Ammar N; Charles Bailey L; Bennett TD; Daniel Brannock M; Brosnahan SB; Chen Y; Chute CG; Divers J; Evans MD; Haendel M; Hall MA; Hirabayashi K; Hornig M; Katz SD; Krieger AC; Loomba J; Lorman V; Mazzotti DR; McMurry J; Moffitt RA; Pajor NM; Pfaff E; Radwell J; Razzaghi H; Redline S; Seibert E; Sekar A; Sharma S; Thaweethai T; Weiner MG; Jae Yoo Y; Zhou A; Thorpe LE
    Sleep; 2023 Sep; 46(9):. PubMed ID: 37166330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and post-acute sequelae of SARS-CoV-2 infection: a review of risk factors and social determinants.
    Wang C; Ramasamy A; Verduzco-Gutierrez M; Brode WM; Melamed E
    Virol J; 2023 Jun; 20(1):124. PubMed ID: 37328773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
    Pretorius E; Vlok M; Venter C; Bezuidenhout JA; Laubscher GJ; Steenkamp J; Kell DB
    Cardiovasc Diabetol; 2021 Aug; 20(1):172. PubMed ID: 34425843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral, Immunologic, and Laboratory Parameters in Patients With and Without Post-Acute Sequelae of SARS-CoV-2 Infection (PASC).
    Ra SH; Chang E; Kwon JS; Kim JY; Son J; Kim W; Jang CY; Jang HM; Bae S; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Lee KH; Kim SH
    J Korean Med Sci; 2024 Sep; 39(35):e237. PubMed ID: 39252682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long COVID or Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and the Urgent Need to Identify Diagnostic Biomarkers and Risk Factors.
    Parums DV
    Med Sci Monit; 2024 Sep; 30():e946512. PubMed ID: 39289865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
    Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
    Front Immunol; 2021; 12():746021. PubMed ID: 35082777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.